UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | December 23, 2021 4:00 P.M. |
Form: | S-4 | ||||||
|
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | December 23, 2021 4:00 P.M. |
Form: | S-4 | ||||||
|
Strong capital base with PureTech Level Cash and Cash Equivalents of $341.4 million1 and Consolidated Cash and Cash Equivalents of $365.9 million2 as of June 30, 2022, excluding up to $115.4 million added post-period3; Operational runway extended into Q1 2026 Significant advancement of PureTech's Wholly Owned Programs, with three clinical trials underway, four completed, and human proof-of-principle achieved for a key PureTech platform Excellent progress across the Founded Entities, including Karuna's positive topline Phase 3 results for KarXT in schizophrenia, Akili's Nasdaq listing and Gelesis' commercial progress with Plenity®4 in the post-period, and four clinical data publications ac
Gelesis' six-month study of weight loss in adults with overweight or obesity who have prediabetes or type 2 diabetes met both of its primary endpoints: the proportion of participants who achieved at least 5% body weight loss (i.e., "Categorical") and the change in body weight after six months of therapy GS200 demonstrated a highly favorable Categorial weight loss response and tolerability in a population that often struggles to lose weight and is at high risk for obesity-related complications; the overall incidence of adverse events (AEs) in adults treated with GS200 was similar to the placebo group ~6 out of 10 GS200-treated adults achieved at least 5% weight loss ("Responders"), losing
New preclinical data presented today at the World of Microbiome Conference suggest adding superabsorbent hydrogel to a high-fat "western-like" diet prevents unfavorable changes in the communities of gut bacteria associated with diet-induced weight gain PureTech Health plc (NASDAQ:PRTC, LSE: PRTC))) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company announced that its Founded Entity, Gelesis Holdings, Inc. (NYSE:GLS) ("Gelesis), released today a poster prPesentation at the World of Microbiome annual meeting in Vienna. The preclinical study showed administration of one of Gelesis' proprietary superabsorbent hydrogels, Gel-B, significantly shifted the composition of the m
SC 13G - CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (0001805087) (Subject)
4 - GELESIS HOLDINGS, INC. (0001805087) (Issuer)
PureTech Health plc (NASDAQ:PRTC) founded entity Gelesis Inc, maker of weight management aid, has completed its business combination with Capstar Special Purpose Acquisition Corp (NYSE:CPSR). The publicly-traded company will be Gelesis Holdings Inc and will begin trading on the New York Stock Exchange under the ticker symbol "GLS" from today. Both Gelesis and Capstar shareholders voted to approve the business combination. The transaction generated approximately $105 million in gross proceeds, which will be mainly used to support the broad launch of Plenity. Related: FDA-Approved Weight Loss Drug Plenity's Parent Announces SPAC Deal: What Investors Should Know. "We are pleased with the
Gainers Splash Beverage Group, Inc. (NYSE:SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas. Nutriband Inc. (NASDAQ:NTRB) shares surged 34.9% to settle at $8.15 on Tuesday. Nutriband and Kindeva Drug Delivery, on Monday, signed a feasibility agreement to develop AVERSA Fentanyl, an abuse deterrent fentanyl patch. Virgin Orbit Holdings, Inc. (NASDAQ:VORB) gained 31.3% to close at $10.57 on above-average volume Tuesday. Virgin Orbit announced via Twitter Monday that the company is still on track to hit the launch window for its third commercia
Gainers TSR, Inc. (NASDAQ:TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year. Accolade, Inc. (NASDAQ:ACCD) gained 27.3% to $24.36 after the company reported Q3 earnings results and raised FY22 sales guidance. Nuverra Environmental Solutions, Inc. (NYSE:NES) shares jumped 22.6% to $2.8450. BARK, Inc. (NYSE:BARK) gained 18% to $4.25. The company said it expects Q3 sales of $140 million, versus analysts’ estimates of $137.3 million. BARK co-founder and executive chairman Matt Meeker will cecome CEO. Nutriband Inc. (NASDAQ:NTRB) jumped 17.2% to $7.08. Nutriband and Kindeva Drug Delivery, on Mo
25-NSE - GELESIS HOLDINGS, INC. (0001805087) (Subject)
8-K - CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (0001805087) (Filer)
425 - CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (0001805087) (Subject)